Innovation: Liposomal and nano-encapsulation for enhanced absorption
Early results from ongoing clinical studies are indicating the GLP-1 medications may successfully treat numerous other conditions including non-alcoholic fatty liver disease (known as metabolic dysfunction-associated steatohepatitis or MASH), sleep apnea, heart failure, diabetic kidney disease and Alzheimers disease
We investigated the diagnostic performance and optimal cut-off values of VCTE and MRE for diagnosing AF
Pastor A, Conn J, MacIsaac RJ, Bonomo Y (2020) Alcohol and illicit drug use in people with diabetes
GLP-1 Receptor Agonists (Semaglutide, Tirzepatide) A meta-analysis found GLP-1 receptor agonists carry a 3.55-fold increased risk of injection site reactions compared to controls
Batch guarantee Every kit ships with a third-party COA matching the vial's batch number